ALSA Ventures
In a research career spanning 30 years, Michael has worked across academic, biotech and pharmaceutical industries, specialising in protein and antibody engineering. He was formerly Head of Lead Discovery and Director of Antibody Technologies within GSKs Biopharm R&D unit. Before this, he served in a senior role at Domantis Ltd and has also performed prominent roles for other biotech companies and organisations working in diverse areas such as immunodiagnostics and epigenetics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
ALSA Ventures
ALSA Ventures is a life science venture capital investor, focused on early-stage novel therapeutics. They invest across a wide spectrum of therapeutic areas, targeting high unmet needs with impactful outcomes for patients and society at large.